Regarding IBD, variants in TLR4 have consistently been associated with CD and UC [4] and interactions between a TLR9 variant and replicated CD susceptibility loci seem to modulate disease susceptibility [5]. This evidence concerns the gene TLR9 and inflammatory bowel disease.